Summary
Lyophilized receptor-positive tissue powders and cytosols, prepared from calf uterus and human breast tumor tissue, are used to assess the validity of routine dextran-coated charcoal estrogen receptor assays. Since 1978 lyophilized reference preparations have been analyzed twice yearly by 18 laboratories in the Netherlands. During 8 consecutive trials 20 different lyophilized samples were studied. The inter-laboratory variability of estrogen receptor results decreased with time. Most laboratories found receptor values around the median value of all groups together, though some participants consistently reported estrogen receptor values that were higher or lower than the median. The variability of estrogen receptor results between labs seemed to be associated with cytosol dilution, determination of non-specific binding, concentration and volume of dextrancoated charcoal, and the use of single dose assays or Scatchard analysis. The agreement on the presence or absence of estrogen receptors was more than 98% for lyophilized reference samples with high receptor content. For samples with low receptor content 85% agreement was observed, while 12% of the assays performed on receptor-negative material were reported to be estrogen receptor-positive. The use of the same protein determination (Coomassie Brilliant Blue) and human serum albumin standard has decreased the interlaboratory variation coefficient of the protein results to 7.5%.
Similar content being viewed by others
References
McGuire WL, Carbone PP, Vollmer EP (eds): Estrogen Receptors in Human Breast Cancer. Raven Press, New York, 1975
DeSombre ER, Jensen EV: Estrophilin assays in breast cancer: Quantitative features and application to the mastectomy specimen. Cancer 46:2783–2788, 1980
Paridaens R, Sylvester RJ, Ferrazzi E, Legros N, Leclercq G, Heuson JC: Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer. Cancer 46:2889–2895, 1980
Lippmann ME, Allegra JC: Quantitative estrogen receptor analysis: The response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease-free interval. Cancer 46:2829–2834, 1980
King RJB, Barnes DM, Hawkins RA, Leake RE, Maynard PV, Roberts MM: Measurement of oestradiol receptors by five institutions on common tissue samples. Brit J Cancer 38:428–430, 1978
Koenders AJ, Geurts-Moespot J, Kho KH, Benraad Th J: Estradiol and progesterone receptor activities in stored lyophilized target tissue. J Steroid Biochem 9:947–950, 1978
Benraad Th, Koenders A: Estradiol receptor activity in lyophilized calf uterus and human breast tumor tissue. Cancer 46:2762–2764, 1980
Koenders A, Benraad Th J: Preparation of lyophilized reference samples for quality control of steroid receptor measurements. Ligand Review 3(4):32–39, 1981
Koenders A, Hendriks T, Benraad Th: Steroid receptors in lyophilized tissues and cytosols of calf uterus and human breast tumor.In GA Sarfaty, AR Nash, and DD Keightly (eds). Estrogen Receptor Assays in Breast Cancer. Laboratory discrepancies and quality assurance. Masson Publishing USA, 1981, pp 126–138
Koenders A, Geurts-Moespot J, Hendriks T, Benraad Th: The Netherlands interlaboratory quality control program of steroid receptor assays in breast cancer.In GA Sarfaty, AR Nash, and DD Keightly (eds). Estrogen Receptor Assays in Breast Cancer. Laboratory discrepancies and quality assurance. Masson Publishing USA, 1981, pp 69–82
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem 72:248–254, 1976
Nash AR, Sarfaty GA: Laboratory variability in estrogen receptor (ER) assays — the Australian experience.In GA Sarfaty, AR Nash, and DD Keightly (eds). Estrogen Receptor Assays in Breast Cancer. Laboratory discrepancies and quality assurance. Masson Publishing USA, 1981, pp 57–68
King RJB: Quality control of estradiol receptor analysis: The United Kingdom experience. Cancer 46:2822–2824, 1980
Fumero S, Piffanelli A: Results of the Italian interlaboratory quality control program for estradiol receptor assay. Tumori 67:301–306, 1981
Zava DT, Guelpa C: A quality control study to assess the interlaboratory variability of routine estrogen and progesterone receptor assays. Eur J Cancer Clin Oncol 18:713–721, 1982
Wittliff JL: Steroid receptor interaction in human breast cancer. Cancer 46:2953–2960, 1980
Cohen JL, Raam S, Gelman R, Wittliff JL: A blinded study of inter- and intra-laboratory variations in the performance of estrogen receptor (ER) assay.In GA Sarfaty, AR Nash, and DD Keightly (eds). Estrogen Receptor Assays in Breast Cancer. Laboratory discrepancies and quality assurance. Masson Publishing USA, 1981, pp 43–56.
Bojar H, Staib W, Beck K, Pilaski J: Investigation on the thermostability of steroid hormone receptors in lyophilized calf uterine tissue powder. Cancer 46:2770–2774, 1980
EORTC Breast Cancer Cooperative Group: Revision of the standards for the assessment of hormone receptors in human breast cancer. Eur J Cancer 16:1513–1515, 1980
Godolphin W, Jacobson H: Quality control of estrogen receptor assays. J Immunoassay 1(3):363–364, 1980
Wittliff JL, Brown AM, Fisher B: Establishment of uniformity in steroid receptor determinations for protocol B-09 of the national surgical adjuvant breast project.In GA Sarfaty, AR Nash, and DD Keightly (eds). Estrogen Receptor Assays in Breast Cancer. Laboratory discrepancies and quality assurance. Masson Publishing USA, 1981, pp 27–39
Raam S, Gelman R, Cohen J: Estrogen receptor assay: interlaboratory and intralaboratory variations in the measurement of receptors using dextran-coated charcoal technique. A study sponsored by ECOG. Eur J Cancer 17:643–649, 1981
Koenders A, Thorpe SM, on behalf of the EORTC Receptor Group: Standardization of steroid receptor assays in human breast Cancer. II. Samples with low receptor content. Eur J Cancer, submitted for publication
Author information
Authors and Affiliations
Consortia
Additional information
Address for reprnts: A. Koenders, Dept. of Experimental and Chemical Endocrinology, St. Radboud Hospital, Geert Grooteplein Z 8, 6500 HB Nijmegen, the Netherlands
List of participating laboratories and institutions: Hospital ‘de Lichtenberg’, Amersfoort; Antoni van Leeuwenhoek Hospital, Amsterdam; Foundation Medical Laboratories, Breda; Foundation of Cooperative Hospitals Delft (SSDZ), Delft; Catharina Hospital, Eindhoven; Hospital ‘de Stadsmaten’ and ‘Ziekenzorg’, Enschede; Academic Hospital, Groningen; The Wever Hospital, Heerlen; Laboratory of Public Health, Leeuwarden; Department of Pathological Chemistry, Academic Hospital, Leiden; Department of Experimental and Chemical Endocrinology, Sint Radboud Hospital, Nijmegen; Scientific Development Group Organon International B.V., Oss; Department of Biochemistry II, Erasmus University Rotterdam, Rotterdam; Rotterdam Radio-Therapeutic Institute/ Dr Daniel den Hoed Clinic, Rotterdam; Institute of Oncology Dr Bernard Verbeeten, Tilburg; Department of Endocrinology, Academic Hospital, Utrecht; Laboratory for Nuclear Medicine ‘Voorburg’, Vught; Sophia Hospital, Zwolle.
Rights and permissions
About this article
Cite this article
Koenders, T., Benraad, T.J. & on behalf of the participating laboratories. Quality control of estrogen receptor assays in the Netherlands. Breast Cancer Res Tr 3, 255–266 (1983). https://doi.org/10.1007/BF01806699
Issue Date:
DOI: https://doi.org/10.1007/BF01806699